Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser.
- DOI
- 10.1136/bjophthalmol-2020-315836
- Published
- 2021 Apr
- Container
- The British journal of ophthalmology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bjophthalmol-2020-315836,
title = {Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser.},
author = {Gale R and Pikoula M and Lee AY and Denaxas S and Egan C and Tufail A and Taylor P and UK EMR Users Group},
year = {2021},
journal = {The British journal of ophthalmology},
doi = {10.1136/bjophthalmol-2020-315836},
url = {https://doi.org/10.1136/bjophthalmol-2020-315836}
}RIS
TY - JOUR TI - Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser. AU - Gale R AU - Pikoula M AU - Lee AY AU - Denaxas S AU - Egan C AU - Tufail A AU - Taylor P AU - UK EMR Users Group PY - 2021 JO - The British journal of ophthalmology DO - 10.1136/bjophthalmol-2020-315836 UR - https://doi.org/10.1136/bjophthalmol-2020-315836 ER -
APA
R, G., M, P., AY, L., S, D., C, E., A, T., P, T., & Group, U. E. U. (2021). Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser.. The British journal of ophthalmology. https://doi.org/10.1136/bjophthalmol-2020-315836
Source records
- pubmed · retrieved 2026-09-27T14:36:31.449Z